By Heather Main I moved to the San Diego from Australia in August 2015, and Paul asked me if I could write something on my first impressions of doing science in the US, as opposed to other countries I have worked/studied in (Australia, Scotland, Sweden and Singapore). If you look at the land size of …
First impressions of the US stem cell environment from an Aussie Read More »
Recently, the Institute of Medicine (IOM) conducted a review of the California Stem Cell Agency, CIRM. IOM has now released a quite lengthy report that makes a number of recommendations on various issues. You can also read a short summary here. Unfortunately, I think that many of the IOM recommendations would be harmful to CIRM …
Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for …
Stem Cell Person of the Year Finalists: time to vote Read More »
Today I was part of a panel discussion on social media for the stem cell cause at the World Stem Cell Summit. My fellow World Stem Cell Summit panel speakers John Hlinko, Amy Adams, and Don Reed all did a great job. Something that one of speakers said in the session that ended right before …
World Stem Cell Summit Day 2: scientists just stick to facts? Read More »
Would you guess that Elon Musk might be into using biotechnology in a high-profile way to try to live far longer than usual, say to age 150? That would have been my assumption. There are countless things about Elon Musk that I really don’t like. I also don’t see many issues on which we are …
I found something Elon Musk & I agree on: pushing back on anti-aging bluster Read More »
Placental biologics firm MiMedx and exosome company Kimera Labs both recently received FDA warning letters. The letter to MiMedx was related to its placental biologics products and procedures. The new warning to Kimera Labs was about its exosome products and an amniotic product. Let’s compare these letters starting with the one to MiMedX. MiMedx warning letter …
Weekly reads: MiMedX & Kimera Labs FDA warnings, NYT on Bryan Johnson, MUSE cell trial Read More »
A New Rochelle doctor has filed suit against the healthcare clinic firm Fountain Life alleging fraud. Now seems like a good time for an update on the firm. Peter Diamandis along with Bob Hariri, life coach Tony Robbins, and surgeon William Kapp founded Fountain Life, an early detection-focused healthcare company. Are they also a longevity firm? To …
Fountain Life update: lawsuit by doc, high performance aging, Celularity trial plan Read More »
There has been a steady stream of encouraging data on stem cells for MS. Particularly for certain kinds of MS. A new study adds to this upbeat direction. Good news on stem cells for MS Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study, Journal of Neurology, Neurosurgery, …
Weekly reads: stem cells for MS, Kimera Labs IND, FDA lawsuit Read More »
An FDA FOIA dump of text messages of former Commissioner Stephen Hahn suggests that a Texas regenerative firm called Direct Biologics benefited from political pressure on him in mid-2020. Then he was asked again to help in early 2021. This was shortly before he resigned at the start of the Biden Administration. The push came from …
FDA leader Stephen Hahn was pressured to aid Texas firm Direct Biologics Read More »
It was a shock to learn today that New York Stem Cell Foundation CEO and Co-Founder Susan Solomon had passed away yesterday after a long battle with ovarian cancer. I met Susan a few times over the years and was always struck by her positive energy. At a practical level she got big things done …
Tributes to NYSCF leader & stem cell advocate Susan Solomon Read More »